Tiny study checks how drug balloon releases medicine in leg arteries

NCT ID NCT06065345

Completed Knowledge-focused Sponsor: Biotronik CRC Inc. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at how a special balloon coated with a drug called sirolimus derivative releases medication into the blood after being used to open blocked leg arteries. Six people with peripheral artery disease took part. The goal was to measure drug levels over time, not to test if the balloon works better than others.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: sirolimus derivative (BIOtorcin)
What this could lead to: If successful, this could help confirm that the drug-coated balloon delivers medication safely and predictably, supporting its use in treating peripheral artery disease.
What could go wrong: This is a very small, early-stage study with only 6 participants, focused on drug levels in the blood, not on whether the treatment actually improves symptoms or prevents artery reblockage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

peripheral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PERIPHERAL ARTERY DISEASE

Contacts and locations

Locations

Royal Perth Hospital

Perth, WAUS, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.